Skip to main content
OpenTrials
Completed

NCT Number: NCT01764178

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperlipidemia Cardiovascular Diseases Dyslipidemias Hyperlipidemias Hypertension Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Vascular Diseases

Age range

20 year–55 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Asan Medical Center

Seoul, 138-736, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male volunteers
  • Age 20-55 years at the time of Screening
  • BMI 19-26 kg/m2 at the time of Screening

Exclusion criteria

  • Received other investigational drug within 90 days prior to the first dose of study drug

Treatment and study plan

Livalo fixed combination drug

Drug

Pitavastatin 4mg / Valsartan 160mg

Pitavastatin, Valsartan

Drug

Pitavastatin 4mg, Valsartan 160mg

Other names: Livalo, Diovan

Primary outcomes

  1. Cmax and AUC of study drugs after single oral administration

    Time frame: 0-48hrs

Secondary outcomes

  1. AUCinf of study drugs after single oral administration

    Time frame: 0-48hrs

  2. t1/2β of study drugs after single oral administration

    Time frame: 0-48hrs

  3. Tmax of study drugs after single oral administration

    Time frame: 0-48hrs

Sponsors and collaborators

Lead sponsor

JW Pharmaceutical

Industry

Registry information

Official study title

A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatn and Valsartan Co-administration and Livalo Complex Product in Healthy Male Subjects

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Jan 9, 2013
Registry last updated
Sep 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.